Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medicago Inc MDCGF

GREY:MDCGF - Post Discussion

Medicago Inc > PMI Has Publicly Spoken about MDG
View:
Post by KingKyle on Feb 01, 2011 8:53am

PMI Has Publicly Spoken about MDG



"These very promising results clearly indicate the potential of Medicago's innovative proprietary plant-based VLP vaccine technology," said Doug Dean, Senior Vice President R&D of Philip Morris International (PMI). PMI currently holds 33% of Medicago's outstanding shares.


I like what I am seeing where PMI has for the first time in my memory issued a statement as part of the news release expressing strong support for MDG technology. Thought it is a brilliant idea to use PMI being largest single owner of MDG to elevate the awareness of this company. Much like Imperial Oil is majority owned by ExxonMobil there is strong backing of a reputable stable majortiy ownership.  I feel we are moving to where we will now see PMI actively issuing statements in support of MDG commercial steps. PMI knows what is at stake here.

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities